108139
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
辛夷花中四氢呋喃型木脂素的药理潜力及分子靶点
Authors Yi X, Xiao Z, Chen J, Chen G, Ma P
Received 19 June 2025
Accepted for publication 9 September 2025
Published 3 October 2025 Volume 2025:19 Pages 9011—9027
DOI https://doi.org/10.2147/DDDT.S547924
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Anastasios Lymperopoulos
Xiaohan Yi, Zixuan Xiao, Jiaxue Chen, Guoren Chen, Ping Ma
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People’s Republic of China
Correspondence: Ping Ma, School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, No.1166, Liutai Avenue, Wenjiang District, Chengdu, 611137, People’s Republic of China, Email maping@cdutcm.edu.cn
Abstract: Tetrahydrofurofuranoid lignans (TFLs) are lignans extracted from the dried flower buds of Magnoliae Flos (MF). The chemical structures of the seven major constituents, magnolin, fargesin, aschantin, lirirresinol B dimethyl ether, epimognolin, eudesmin, and kobusin, are strikingly similar. Despite their potential therapeutic effects against various pathological conditions, their underlying mechanisms have not been systematically analyzed. The primary objective of this review was to examine the mechanisms by which TFLs exert therapeutic effects on inflammation, allergies, cancer, cardiovascular diseases, metabolic disorders and osteoarticular diseases. Data were retrieved from scientific databases, including PubMed, Web of Science, and Google Scholar, up to November 2024. The search terms employed included “Magnoliae Flos” or “Magnolia” and “Lignans” “Tetrahydrofurofuranoid” “Magnolin” “Fargesin” “Aschantin” “Lirirresinol B dimethyl ether” “Epimagnolin” “Eudesmin” and “Kobusin.” TFLs have been demonstrated to treat various inflammatory diseases through inhibition of signaling pathways, including NF-κB and MAPK. Additionally, allergic reactions are suppressed via inhibition of mast cell degranulation-related receptors. Furthermore, anticancer activity is achieved by triggering signaling pathways such as PI3K/AKT/mTOR, ERK/MEK, and P53. Besides enhancing glucose metabolism, TFLs suppress adipogenesis through downregulation of pathways involving PI3K/Akt, Akt/AMPK, and P-selectin expression. Fargesin, a notable compound derived from MF, exerts cardioprotective effects by inhibiting the cAMP/PKA pathway and counteracts atherosclerosis through the downregulation of the TLR4/NF-κB signaling pathway. Notably, TFLs also demonstrate the ability to reduce melanin synthesis by suppressing tyrosinase, associated proteins, MITF, and enzymes involved in melanogenesis. Growing research highlights diverse pharmacological attributes of TFLs, providing critical insights for future studies aimed at developing novel therapeutics exhibiting enhanced efficacy and minimal toxicity for inflammation, cancer, cardiovascular disorders, diabetes, skin ultraviolet damage and osteoporosis.
Keywords: Xin-yi, Magnolia, Lignans, pharmacology, mechanisms, toxicity
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People’s Republic of China
Correspondence: Ping Ma, School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, No.1166, Liutai Avenue, Wenjiang District, Chengdu, 611137, People’s Republic of China, Email maping@cdutcm.edu.cn
Abstract: Tetrahydrofurofuranoid lignans (TFLs) are lignans extracted from the dried flower buds of Magnoliae Flos (MF). The chemical structures of the seven major constituents, magnolin, fargesin, aschantin, lirirresinol B dimethyl ether, epimognolin, eudesmin, and kobusin, are strikingly similar. Despite their potential therapeutic effects against various pathological conditions, their underlying mechanisms have not been systematically analyzed. The primary objective of this review was to examine the mechanisms by which TFLs exert therapeutic effects on inflammation, allergies, cancer, cardiovascular diseases, metabolic disorders and osteoarticular diseases. Data were retrieved from scientific databases, including PubMed, Web of Science, and Google Scholar, up to November 2024. The search terms employed included “Magnoliae Flos” or “Magnolia” and “Lignans” “Tetrahydrofurofuranoid” “Magnolin” “Fargesin” “Aschantin” “Lirirresinol B dimethyl ether” “Epimagnolin” “Eudesmin” and “Kobusin.” TFLs have been demonstrated to treat various inflammatory diseases through inhibition of signaling pathways, including NF-κB and MAPK. Additionally, allergic reactions are suppressed via inhibition of mast cell degranulation-related receptors. Furthermore, anticancer activity is achieved by triggering signaling pathways such as PI3K/AKT/mTOR, ERK/MEK, and P53. Besides enhancing glucose metabolism, TFLs suppress adipogenesis through downregulation of pathways involving PI3K/Akt, Akt/AMPK, and P-selectin expression. Fargesin, a notable compound derived from MF, exerts cardioprotective effects by inhibiting the cAMP/PKA pathway and counteracts atherosclerosis through the downregulation of the TLR4/NF-κB signaling pathway. Notably, TFLs also demonstrate the ability to reduce melanin synthesis by suppressing tyrosinase, associated proteins, MITF, and enzymes involved in melanogenesis. Growing research highlights diverse pharmacological attributes of TFLs, providing critical insights for future studies aimed at developing novel therapeutics exhibiting enhanced efficacy and minimal toxicity for inflammation, cancer, cardiovascular disorders, diabetes, skin ultraviolet damage and osteoporosis.
Keywords: Xin-yi, Magnolia, Lignans, pharmacology, mechanisms, toxicity